Additionally, a recent report on the gastrointestinal peptides proguanylin (GUCA2A) and prouroguanylin (GUCA2B), which play major roles in obesity and satiety, demonstrated a protective effect against lipotoxicity and mitochondrial dysfunction. This evidence concerns the gene GUCA2B and Obesity.